VANESSA DOOBAY: Open Payments
NPI 1689449548 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 25 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $665 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $342 |
| ABBVIE INC. | 4 | $149 |
| Collegium Pharmaceutical, Inc. | 1 | $63 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Bausch Health US, LLC | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, Jornay PM, Qelbree, APLENZIN, VIVITROL.
Industry payments across NJ — which companies pay providers there.
